N. Anfossi, P. Andre, S. Guia, C. S. Falk, S. Roetynck et al., Human NK cell education by inhibitory receptors for MHC class I, Immunity, vol.25, pp.331-342, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00091535

M. A. Cooper, T. A. Fehniger, and M. A. Caligiuri, The biology of human natural killer-cell subsets, Trends Immunol, vol.22, pp.633-640, 2001.

A. Poli, T. Michel, M. Theresine, A. E. Hentges, F. Zimmer et al., CD56bright natural killer (NK) cells: an important NK cell subset, Immunology, vol.126, pp.458-465, 2009.

R. Kiessling, E. Klein, and H. Wigzell, Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype, Eur J Immunol, vol.5, pp.112-117, 1975.

K. Karre and . Cells, MHC class I molecules and the missing self, Scand J Immunol, vol.55, pp.221-228, 2002.

K. Karre, Natural killer cell recognition of missing self, Nat Immunol, vol.9, pp.477-480, 2008.

L. L. Lanier, NK cell recognition, Annu Rev Immunol, vol.23, pp.225-274, 2005.

M. Uhrberg, Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation, Mol Immunol, vol.42, pp.471-475, 2005.

L. Ruggeri, M. Capanni, E. Urbani, K. Perruccio, W. D. Shlomchik et al., Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants, Science, vol.295, pp.2097-2100, 2002.

L. Ruggeri, A. Mancusi, M. Capanni, E. Urbani, A. Carotti et al., Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value, Blood, vol.110, pp.433-440, 2007.

A. Lundqvist, J. P. Mccoy, L. Samsel, and R. Childs, Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors, Blood, vol.109, pp.3603-3606, 2007.

J. S. Miller, Y. Soignier, A. Panoskaltsis-mortari, S. A. Mcnearney, G. H. Yun et al., Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer, Journal of Translational Medicine, vol.105, pp.3051-3057, 2005.

K. J. Malmberg, Y. T. Bryceson, M. Carlsten, S. Andersson, A. Bjorklund et al., NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy, Cancer Immunol Immunother, vol.57, pp.1541-1552, 2008.

L. Ruggeri, A. Mancusi, K. Perruccio, E. Burchielli, M. F. Martelli et al., Natural killer cell alloreactivity for leukemia therapy, J Immunother, vol.28, pp.175-182, 2005.

E. Alici, T. Sutlu, B. Bjorkstrand, M. Gilljam, B. Stellan et al., Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components, Blood, vol.111, pp.3155-3162, 2008.

S. H. Medina and M. E. El-sayed, Dendrimers as Carriers for Delivery of Chemotherapeutic Agents, Chem Rev, vol.109, pp.3141-3157, 2009.

L. Vannucci, A. Fiserova, K. Sadalapure, T. K. Lindhorst, M. Kuldova et al., Effects of Nacetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivo, Int J Oncol, vol.23, pp.285-296, 2003.

K. C. Sheng, M. Kalkanidis, D. S. Pouniotis, S. Esparon, C. K. Tang et al., Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo, Eur J Immunol, vol.38, pp.424-436, 2008.

M. Poupot, L. Griffe, P. Marchand, A. Maraval, O. Rolland et al., Design of phosphorylated dendritic architectures to promote human monocyte activation, Faseb J, vol.20, pp.2339-2351, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-02472268

O. Rolland, L. Griffe, M. Poupot, A. Maraval, A. Ouali et al., Tailored control and optimisation of the number of phosphonic acid termini on phosphorus-containing dendrimers for the ex-vivo activation of human monocytes, Chemistry, vol.14, pp.4836-4850, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-02472260

S. Fruchon, M. Poupot, L. Martinet, C. O. Turrin, J. P. Majoral et al., Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer, J Leukoc Biol, vol.85, pp.553-562, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-02472254

L. Griffe, M. Poupot, P. Marchand, A. Maraval, C. O. Turrin et al., Multiplication of human natural killer cells by nanosized phosphonatecapped dendrimers, Angew Chem Int Ed Engl, vol.46, pp.2523-2526, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-02472267

F. Ghiringhelli, C. Menard, M. Terme, C. Flament, J. Taieb et al., CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner, J Exp Med, vol.202, pp.1075-1085, 2005.
URL : https://hal.archives-ouvertes.fr/pasteur-00020140

N. Ralainirina, A. Poli, T. Michel, L. Poos, A. E. Hentges et al., Control of NK cell functions by CD4+CD25+ regulatory T cells, J Leukoc Biol, vol.81, pp.144-153, 2007.

A. M. Thornton, E. E. Donovan, C. A. Piccirillo, and E. M. Shevach, Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function, J Immunol, vol.172, pp.6519-6523, 2004.

W. Liu, A. L. Putnam, Z. Xu-yu, G. L. Szot, M. R. Lee et al., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells, J Exp Med, vol.203, pp.1701-1711, 2006.

S. Carlens, M. Gilljam, B. J. Chambers, J. Aschan, H. Guven et al., A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells, Hum Immunol, vol.62, pp.1092-1098, 2001.

Y. Jin, E. Knudsen, L. Wang, Y. Bryceson, B. Damaj et al., Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation, Blood, vol.101, pp.4909-4915, 2003.

J. S. Miller, S. Oelkers, C. Verfaillie, and P. Mcglave, Role of monocytes in the expansion of human activated natural killer cells, Blood, vol.80, pp.2221-2229, 1992.

J. Dunne, S. Lynch, C. O'farrelly, S. Todryk, J. E. Hegarty et al., Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15, J Immunol, vol.167, pp.3129-3138, 2001.

M. R. Walker, D. J. Kasprowicz, V. H. Gersuk, A. Benard, M. Van-landeghen et al., Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells, J Clin Invest, vol.112, pp.1437-1443, 2003.

P. Klenerman, V. Cerundolo, and P. R. Dunbar, Tracking T cells with tetramers: new tales from new tools, vol.2, pp.263-272, 2002.

M. Poupot and J. J. Fournie, Non-peptide antigens activating human Vgamma9/Vdelta2 T lymphocytes
URL : https://hal.archives-ouvertes.fr/inserm-02472273

, Immunol Lett, vol.95, pp.129-138, 2004.

D. S. Mestel, C. Assaf, M. Steinhoff, M. Beyer, M. Moebs et al., Emerging drugs in cutaneous T cell lymphoma, Expert Opin Emerg Drugs, vol.13, pp.345-361, 2008.